Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), reported that it will be in attendance at the Healthcare Week taking place together with the J.P. Morgan Healthcare Conference in San Francisco (Press release, Biomica, DEC 28, 2022, View Source [SID1234625649]). The conference is one of the industry’s largest conferences of the year.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This follows Biomica’s recent successful financing round of $20 million, led by Shanghai Healthcare Capital, a leading Chinese private equity fund. In attendance will be Dr. Elran Haber, CEO of Biomica, throughout the week from Monday, January 9 until Wednesday, January 11, 2023.

Dr. Haber will be available for one-on-one meetings throughout the week, and those interested should be in touch with Biomica’s investor or public relations team.